https://www.selleckchem.com/pr....oducts/sotrastaurin-
Background Limited data is available for reliable and accurate predictors of in-hospital mortality in patients diagnosed with COVID-19. Methods This scientific study is a retrospective cohort study of patients without a known history of liver diseases who were hospitalized with COVID-19 viral infection. Patients were stratified into low score groups (Model of End-Stage Liver Disease [MELD] score less then 1 and high score groups (MELD ≥1. Clinical outcomes were evaluated, including in-hospital mortality, hospital length
Aimer
Commentaire
Partagez
